Literature DB >> 23471344

Catheter ablation of atrial fibrillation to reduce stroke risk.

B Schmidt1, S Bordignon, A Fürnkranz, K R J Chun.   

Abstract

Stroke is the most devastating complication of atrial fibrillation (AF), and the latter increases the risk of stroke by almost fivefold. AF elimination by catheter ablation should lower the risk of thromboembolic complications. Several studies support this hypothesis, demonstrating rates of stroke in AF patients similar to non-AF populations after successful catheter ablation. Widespread discontinuation of oral anticoagulation after catheter ablation is currently not supported by scientific data but it may be a viable option for patients with a CHA2DS2VASc score of less than 2 and a well-documented stable sinus rhythm.

Entities:  

Mesh：

Year:  2013        PMID： 23471344     DOI： 10.1007/s00059-013-3776-4

Source DB:  PubMed          Journal:  Herz        ISSN： 0340-9937            Impact factor:   1.443


  25 in total

1.  The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation.

Authors:  Sakis Themistoclakis; Andrea Corrado; Francis E Marchlinski; Pierre Jais; Erica Zado; Antonio Rossillo; Luigi Di Biase; Robert A Schweikert; Walid I Saliba; Rodney Horton; Prasant Mohanty; Dimpi Patel; David J Burkhardt; Oussama M Wazni; Aldo Bonso; David J Callans; Michel Haissaguerre; Antonio Raviele; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2010-02-23       Impact factor: 24.094

2.  Natural history and long-term outcomes of ablated atrial fibrillation.

Authors:  Ayman A Hussein; Walid I Saliba; David O Martin; Mandeep Bhargava; Minerva Sherman; Christina Magnelli-Reyes; Mohammed Chamsi-Pasha; Seby John; Michelle Williams-Adrews; Bryan Baranowski; Thomas Dresing; Thomas Callahan; Mohamed Kanj; Patrick Tchou; Bruce D Lindsay; Andrea Natale; Oussama Wazni
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-04-14

3.  The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: data from the Heart and Soul Study.

Authors:  Christine C Welles; Mary A Whooley; Beeya Na; Peter Ganz; Nelson B Schiller; Mintu P Turakhia
Journal:  Am Heart J       Date:  2011-08-09       Impact factor: 4.749

4.  Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation.

Authors:  T Jared Bunch; Brian G Crandall; J Peter Weiss; Heidi T May; Tami L Bair; Jeffrey S Osborn; Jeffrey L Anderson; Joseph B Muhlestein; Benjamin D Horne; Donald L Lappe; John D Day
Journal:  J Cardiovasc Electrophysiol       Date:  2011-03-15

5.  Aspirin for preventing the recurrence of venous thromboembolism.

Authors:  Cecilia Becattini; Giancarlo Agnelli; Alessandro Schenone; Sabine Eichinger; Eugenio Bucherini; Mauro Silingardi; Marina Bianchi; Marco Moia; Walter Ageno; Maria Rita Vandelli; Elvira Grandone; Paolo Prandoni
Journal:  N Engl J Med       Date:  2012-05-24       Impact factor: 91.245

6.  Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation.

Authors:  Hakan Oral; Aman Chugh; Mehmet Ozaydin; Eric Good; Jackie Fortino; Sundar Sankaran; Scott Reich; Petar Igic; Darryl Elmouchi; David Tschopp; Alan Wimmer; Sujoya Dey; Thomas Crawford; Frank Pelosi; Krit Jongnarangsin; Frank Bogun; Fred Morady
Journal:  Circulation       Date:  2006-08-14       Impact factor: 29.690

7.  Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up?

Authors:  Rukshen Weerasooriya; Paul Khairy; Jean Litalien; Laurent Macle; Meleze Hocini; Frederic Sacher; Nicolas Lellouche; Sebastien Knecht; Matthew Wright; Isabelle Nault; Shinsuke Miyazaki; Christophe Scavee; Jacques Clementy; Michel Haissaguerre; Pierre Jais
Journal:  J Am Coll Cardiol       Date:  2011-01-11       Impact factor: 24.094

8.  Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study.

Authors:  Scott D Corley; Andrew E Epstein; John P DiMarco; Michael J Domanski; Nancy Geller; H Leon Greene; Richard A Josephson; Joyce C Kellen; Richard C Klein; Andrew D Krahn; Mary Mickel; L Brent Mitchell; Joy Dalquist Nelson; Yves Rosenberg; Eleanor Schron; Lynn Shemanski; Albert L Waldo; D George Wyse
Journal:  Circulation       Date:  2004-03-08       Impact factor: 29.690

9.  Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation.

Authors:  Meytal Avgil Tsadok; Cynthia A Jackevicius; Vidal Essebag; Mark J Eisenberg; Elham Rahme; Karin H Humphries; Jack V Tu; Hassan Behlouli; Louise Pilote
Journal:  Circulation       Date:  2012-11-02       Impact factor: 29.690

10.  Successful catheter ablation reduces the risk of cardiovascular events in atrial fibrillation patients with CHA2DS2-VASc risk score of 1 and higher.

Authors:  Yenn-Jiang Lin; Tze-Fan Chao; Hsuan-Ming Tsao; Shih-Lin Chang; Li-Wei Lo; Chern-En Chiang; Yu-Feng Hu; Pai-Feng Hsu; Shao-Yuan Chuang; Cheng-Hung Li; Fa-Po Chung; Yun-Yu Chen; Tsu-Juey Wu; Ming-Hsiung Hsieh; Shih-Ann Chen
Journal:  Europace       Date:  2012-11-28       Impact factor: 5.214
View more
  1 in total

Review 1.  Atrial Fibrillation In Heart Failure: New Directions In Diagnosis, Risk Assessment And Risk Reduction.

Authors:  Richard J A Till; Martin R Cowie
Journal:  J Atr Fibrillation       Date:  2014-04-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.